tirzepatide psoriatic arthritis Results of the phase 3b TOGETHER-PsA trial showed ixekizumab administered together with in comorbid overweight or obese adults with showed clinically meaningful improvement of psoriatic disease, physical function, weight Treating Psoriatic Arthritis: Skin, Joints,

Your mental health provider should know you are starting GLP-1 therapy so they can adjust psychiatric medication doses or monitor for side effects if needed

The following GLP-1RAs showed a significantly higher odds ratio of discontinuation due to adverse events compared with placebo: lixisenatide (odds ratio 2.86 (95% confidence interval 1.48 to 5.51)), semaglutide (2.61 (1.56 to 4.37)), exenatide (2.39 (1.14 to 4.98)), tirzepatide (2.30 (1.30 to 4.09)), and liraglutide (2.15 (1.26 to 3.69)) (fig 8A)

Turner, J

If you're experiencing side effects or want to adjust your dosing schedule, contact PlexusDx to discuss modifications with your prescriber rather than stopping on your own

Because of these differences, many type 2 diabetics prefer Tirzepatide as a more holistic solution for both glucose management and weight loss